[Antihypertensive effect of spironolactone (author's transl)].
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D001810:Blood Volume / Q000187:drug effects; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000652:urine; D005260:Female; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010919:Placebos; D010953:Plasma Volume / Q000187:drug effects; D012083:Renin / Q000097:blood; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use; D014642:Vanilmandelic Acid / Q000652:urine
D010919:Placebos; D013148:Spironolactone; D014642:Vanilmandelic Acid; D012083:Renin; D009638:Norepinephrine; D004837:Epinephrine
Untersuchungen zur antihypertensiven Wirkung von Spironolactone